By Matt Brignall, ND
Healthnotes Newswire (August 31, 2000)—Cancer patients who use complementary and alternative medicine are not any less likely to undergo conventional medical therapies, according to a study published this month in the journal Cancer.1
In this new study, 172 Austrian cancer patients undergoing radiation therapy filled out a questionnaire asking about use of and interest in complementary and alternative medicine (CAM). Of those who responded, 24% reported using CAM therapies, and another 31% reported being interested in trying these methods. Multivitamin therapy, herbal medicine, and homeopathy were the treatments most often used. Patients who reported using CAM treatments were similar to the rest of the respondents in measures of psychological disturbance, compliance with conventional treatment, and trust for their oncologist.
CAM use among cancer patients has ranged from 7 to 64% in different studies,2 depending on where the study was performed, how CAM was defined, and possibly how comfortable patients were disclosing their use of CAM treatments to their practitioners. Many medical doctors have looked at nonconventional cancer treatments with concern,3 in part because of the possibility that CAM treatments could interfere with the actions of,4 or even cause patients to abandon, conventional treatments. In fact, one study found that 40% of cancer patients using CAM treatments discontinued conventional therapies.5 Other studies, however, have agreed with this new study, showing that compliance with conventional therapy was similar in those who pursued CAM treatments and those who did not.6 7
These data appear to refute the findings of a paper published last year that concluded that women who seek alternative treatments for breast cancer are more anxious about their condition than women who do not use CAM.8 The patients using CAM in the new study did not report any more or less psychological distress than those who did not use these therapies. Other studies comparing the mental health of users and nonusers of CAM have had mixed results, with some showing increased anxiety in CAM users9 and others showing no difference.10
Unfortunately, none of the studies mentioned above evaluated whether any of the CAM treatments actually work. Studies on CAM therapies for cancer are very limited, and most are only preliminary.11 12 There is an urgent need for CAM therapies to be tested in large, well-designed studies, so that cancer patients and their doctors will know what works and what does not.
References1. Soellner W, Maislinger S, DeVries A, et al. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. Cancer 2000;89:873–80.
2. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. Cancer 1998;83:777–82.
3. Hauser SP. Unproven methods in cancer treatment. Curr Opin Oncol 1993;5:646–54.
4. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003–8.
5. Cassileth BR, Lusk EJ, Strause TD, Bodenheimer BJ. Contemporary unorthodox treatment in cancer medicine: a study of patients, treatments, and practitioners. Ann Intern Med 1984;101:105–12.
6. Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. Cancer 1992;42:181–91.
7. Soellner W, Zingg-Schir M, Rumpold G, Fritsch P. Attitude towards alternative therapy, compliance with standard treatment and need for emotional support in patients with melanoma. Arch Dermatol 1997;133:316–21.
8. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733–9.
9. Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994;309:86–9.
10. Soellner W, Zingg-Schir M, Rumpold G, Fritsch P. Attitude towards alternative therapy, compliance with standard treatment and need for emotional support in patients with melanoma. Arch Dermatol 1997;133:316–21.
11. Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer 1999;33:117–24.
12. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun 1994;199:1504–8. Matt Brignall, ND, is a research associate at the Tahoma Clinic in Kent, Washington, and a contributor to the Healthnotes Review of Complementary and Integrative Medicine.
This article is provided by Healthnotes for theBetterHealthStore. Copyright © 2000 Healthnotes, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.